Molecular Partners AG
(NAS:MOLN)
$
6.23
-0.47 (-7.01%)
Market Cap: 206.71 Mil
Enterprise Value: 5.32 Mil
PE Ratio: 0
PB Ratio: 1.02
GF Score: 66/100 - Full Year 2023 Molecular Partners AG Earnings Call TranscriptMar 15, 2024$3.96 (+2.46%)Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Half Year 2023 Molecular Partners AG Earnings Call TranscriptAug 25, 2023$6 (+1.89%)Earnings
- Molecular Partners AG at TD Cowen Inc Radiopharmaceutical Innovation Summit (Virtual) TranscriptJun 20, 2023
- Molecular Partners AG at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Full Year 2022 Molecular Partners AG Earnings Call TranscriptMar 10, 2023$5.92 (-3.74%)Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Half Year 2022 Molecular Partners AG Earnings Call TranscriptAug 26, 2022$6.43 (-7.35%)Earnings
- Full Year 2021 Molecular Partners AG Earnings Call TranscriptMar 16, 2022$20.38 (-0.65%)Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Molecular Partners AG Corporate Call TranscriptJan 10, 2022
- Molecular Partners AG to Host Oncology Day (Virtual) TranscriptDec 15, 2021
- Molecular Partners AG at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Half Year 2021 Molecular Partners AG Earnings Call TranscriptAug 26, 2021$19.95 (-0.25%)Earnings
- Molecular Partners AG at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Full Year 2020 Molecular Partners AG Earnings Call TranscriptFeb 05, 2021Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Molecular Partners AG - Special Call TranscriptDec 17, 2020
- Molecular Partners AG at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Half Year 2020 Molecular Partners AG Earnings Call TranscriptAug 26, 2020Earnings
- Molecular Partners AG - Special Call TranscriptJun 26, 2020
- Full Year 2019 Molecular Partners AG Earnings Call TranscriptFeb 06, 2020Earnings
- Molecular Partners AG at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Molecular Partners AG - Special Call TranscriptDec 12, 2019
- Half Year 2019 Molecular Partners AG Earnings Call TranscriptAug 27, 2019Earnings
- Full Year 2018 Molecular Partners AG Earnings Call TranscriptFeb 07, 2019Earnings
Molecular Partners AG at TD Cowen Inc Radiopharmaceutical Innovation Summit (Virtual) Transcript
Jun 20, 2023 / 04:00PM GMT
Release Date Price:
$6.51
(-4.08%)
Mike Nedelcovych
TD Cowen, Inc. - Analyst
Good afternoon, everyone. Welcome to the Molecular Partners session of Cowen's inaugural Radiopharmaceutical Innovation Summit. My name is Mike Nedelcovych. I'm one of the pharmaceutical analysts at TD Cowen. And I'm very pleased to welcome to the chat, Dr. Patrick Amstutz, who is CEO of Molecular Partners; as well as Dr. Danny Steiner, who is Senior Vice President of Research.
Patrick, Danny, thanks for joining us.
Patrick Amstutz
Molecular Partners AG - CEO, Member of the Management Board, Member of the Board of Directors
Thanks, Mike. Great for having us.
Danny Steiner
Molecular Partners AG - SVP Research
Thanks, Mike (multiple speakers)
Questions & Answers
Mike Nedelcovych
TD Cowen, Inc. - Analyst
Lovely. Let's start with first a broad question for investors who may not be so familiar with your company and your efforts. Can you give us first some background on your protein engineering platform? So what
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)